The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company’s next-generation device and will be available in the U.S. in late 2026.
NEWARK, Del., June 2, 2026 /PRNewswire/ -- According to the latest market analysis by Future Market Insights, the global waste-derived pyrolysis oil market is gaining momentum as...
LONDON, June 2, 2026 /PRNewswire/ -- ICIS, a global leader in commodity intelligence, announced it has acquired the AMI Plastics Market Intelligence Dataset, strengthening its ability...
LONDON, June 2, 2026 /PRNewswire/ -- ICIS, a global leader in commodity intelligence, announced it has acquired the AMI Plastics Market Intelligence Dataset, strengthening its ability...
DELRAY BEACH, Fla., Aug. 15, 2025 /PRNewswire/ -- The report 'Pressure Sensitive Adhesive Tapes Market by Type (Single-Sided, Double-Sided), Adhesive Type (Acrylic, Rubber), Technology...
DELRAY BEACH, Fla., Aug. 15, 2025 /PRNewswire/ -- The report 'Pressure Sensitive Adhesive Tapes Market by Type (Single-Sided, Double-Sided), Adhesive Type (Acrylic, Rubber), Technology...
New agreement will help meet the growing demand for high-performance formulations in polyurethane, coatings, and adhesives production in the United States and Canada
DOWNERS GROVE,...
New agreement will help meet the growing demand for high-performance formulations in polyurethane, coatings, and adhesives production in the United States and Canada
DOWNERS GROVE,...
WUHAN, China, Aug. 13, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in...
DELRAY BEACH, Fla., Aug. 13, 2025 /PRNewswire/ -- The report "Automotive Refinish Coatings Market by Layer (Clearcoat, Basecoat, Primer), Resin Type (Polyurethane, Epoxy, Acrylic, Alkyd),...
DELRAY BEACH, Fla., Aug. 13, 2025 /PRNewswire/ -- The report "Automotive Refinish Coatings Market by Layer (Clearcoat, Basecoat, Primer), Resin Type (Polyurethane, Epoxy, Acrylic, Alkyd),...
VICTORIA, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the second quarter of 2025 and provided a business update. All dollar values are in U.S. dollars unless stated otherwise.
60 finalists for SG60 milestone edition selected by an international panel of judges and visionary partnersFocus on empowering Urban Solutions and Sustainability to solve...